BCG Vaccine for Tuberculosis (TB) Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
BCG Vaccine for Tuberculosis (TB) Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Get latest Market Research Reports on BCG Vaccine for Tuberculosis (TB) . Industry analysis and Market Report on BCG Vaccine for Tuberculosis (TB) is a syndicated market report, published as Global BCG Vaccine for Tuberculosis (TB) Market Research Report . It is complete Research Study and Industry Analysis of BCG Vaccine for Tuberculosis (TB) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
This report aims to provide a comprehensive presentation of the global market for BCG Vaccine for Tuberculosis (TB) study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global BCG Vaccine for Tuberculosis (TB) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global BCG Vaccine for Tuberculosis (TB) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five BCG Vaccine for Tuberculosis (TB) companies in 2021 (%)
The global BCG Vaccine for Tuberculosis (TB) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immune Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of BCG Vaccine for Tuberculosis (TB) include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL and Statens Serum Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the BCG Vaccine for Tuberculosis (TB) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global BCG Vaccine for Tuberculosis (TB) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, by Type, 2021 (%)
Immune Type
Therapy Type
Global BCG Vaccine for Tuberculosis (TB) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global BCG Vaccine for Tuberculosis (TB) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCG Vaccine for Tuberculosis (TB) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies BCG Vaccine for Tuberculosis (TB) revenues share in global market, 2021 (%)
Key companies BCG Vaccine for Tuberculosis (TB) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies BCG Vaccine for Tuberculosis (TB) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 BCG Vaccine for Tuberculosis (TB) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global BCG Vaccine for Tuberculosis (TB) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global BCG Vaccine for Tuberculosis (TB) Overall Market Size
2.1 Global BCG Vaccine for Tuberculosis (TB) Market Size: 2021 VS 2028
2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global BCG Vaccine for Tuberculosis (TB) Sales: 2017-2028
3 Company Landscape
3.1 Top BCG Vaccine for Tuberculosis (TB) Players in Global Market
3.2 Top Global BCG Vaccine for Tuberculosis (TB) Companies Ranked by Revenue
3.3 Global BCG Vaccine for Tuberculosis (TB) Revenue by Companies
3.4 Global BCG Vaccine for Tuberculosis (TB) Sales by Companies
3.5 Global BCG Vaccine for Tuberculosis (TB) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 BCG Vaccine for Tuberculosis (TB) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
3.8 Tier 1, Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Players in Global Market
3.8.1 List of Global Tier 1 BCG Vaccine for Tuberculosis (TB) Companies
3.8.2 List of Global Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global BCG Vaccine for Tuberculosis (TB) Market Size Markets, 2021 & 2028
4.1.2 Immune Type
4.1.3 Therapy Type
4.2 By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
4.2.1 By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2022
4.2.2 By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2023-2028
4.2.3 By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2017-2028
4.3 By Type - Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
4.3.1 By Type - Global BCG Vaccine for Tuberculosis (TB) Sales, 2017-2022
4.3.2 By Type - Global BCG Vaccine for Tuberculosis (TB) Sales, 2023-2028
4.3.3 By Type - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2017-2028
4.4 By Type - Global BCG Vaccine for Tuberculosis (TB) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global BCG Vaccine for Tuberculosis (TB) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
5.2.1 By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2022
5.2.2 By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2023-2028
5.2.3 By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2017-2028
5.3 By Application - Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
5.3.1 By Application - Global BCG Vaccine for Tuberculosis (TB) Sales, 2017-2022
5.3.2 By Application - Global BCG Vaccine for Tuberculosis (TB) Sales, 2023-2028
5.3.3 By Application - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2017-2028
5.4 By Application - Global BCG Vaccine for Tuberculosis (TB) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global BCG Vaccine for Tuberculosis (TB) Market Size, 2021 & 2028
6.2 By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
6.2.1 By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2022
6.2.2 By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2023-2028
6.2.3 By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2017-2028
6.3 By Region - Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
6.3.1 By Region - Global BCG Vaccine for Tuberculosis (TB) Sales, 2017-2022
6.3.2 By Region - Global BCG Vaccine for Tuberculosis (TB) Sales, 2023-2028
6.3.3 By Region - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.4.2 By Country - North America BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.4.3 US BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.4.4 Canada BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.4.5 Mexico BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.5.2 By Country - Europe BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.5.3 Germany BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.4 France BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.5 U.K. BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.6 Italy BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.7 Russia BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.8 Nordic Countries BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.9 Benelux BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.6.2 By Region - Asia BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.6.3 China BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6.4 Japan BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6.5 South Korea BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6.6 Southeast Asia BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6.7 India BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.7.2 By Country - South America BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.7.3 Brazil BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.7.4 Argentina BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.8.3 Turkey BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.8.4 Israel BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.8.5 Saudi Arabia BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.8.6 UAE BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.1.4 Merck BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Corporate Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.2.4 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Pasteur Key News
7.3 Japan BCG Lab
7.3.1 Japan BCG Lab Corporate Summary
7.3.2 Japan BCG Lab Business Overview
7.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.3.5 Japan BCG Lab Key News
7.4 China National Biotec
7.4.1 China National Biotec Corporate Summary
7.4.2 China National Biotec Business Overview
7.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.4.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.4.5 China National Biotec Key News
7.5 AJ Vaccines
7.5.1 AJ Vaccines Corporate Summary
7.5.2 AJ Vaccines Business Overview
7.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.5.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.5.5 AJ Vaccines Key News
7.6 Serum Institute of India
7.6.1 Serum Institute of India Corporate Summary
7.6.2 Serum Institute of India Business Overview
7.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.6.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.6.5 Serum Institute of India Key News
7.7 Intervax
7.7.1 Intervax Corporate Summary
7.7.2 Intervax Business Overview
7.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.7.4 Intervax BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.7.5 Intervax Key News
7.8 GSBPL
7.8.1 GSBPL Corporate Summary
7.8.2 GSBPL Business Overview
7.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.8.4 GSBPL BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.8.5 GSBPL Key News
7.9 Statens Serum Institute
7.9.1 Statens Serum Institute Corporate Summary
7.9.2 Statens Serum Institute Business Overview
7.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.9.4 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.9.5 Statens Serum Institute Key News
7.10 Biomed Lublin
7.10.1 Biomed Lublin Corporate Summary
7.10.2 Biomed Lublin Business Overview
7.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.10.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.10.5 Biomed Lublin Key News
7.11 ANLIS Malbran
7.11.1 ANLIS Malbran Corporate Summary
7.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Business Overview
7.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.11.5 ANLIS Malbran Key News
7.12 Fundação Ataulpho de Paiva
7.12.1 Fundação Ataulpho de Paiva Corporate Summary
7.12.2 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Business Overview
7.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.12.4 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.12.5 Fundação Ataulpho de Paiva Key News
7.13 BB-NCIPD
7.13.1 BB-NCIPD Corporate Summary
7.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Business Overview
7.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.13.5 BB-NCIPD Key News
7.14 Taj Pharmaceuticals
7.14.1 Taj Pharmaceuticals Corporate Summary
7.14.2 Taj Pharmaceuticals Business Overview
7.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.14.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.14.5 Taj Pharmaceuticals Key News
7.15 Bio Farma
7.15.1 Bio Farma Corporate Summary
7.15.2 Bio Farma Business Overview
7.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.15.4 Bio Farma BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.15.5 Bio Farma Key News
7.16 Microgen
7.16.1 Microgen Corporate Summary
7.16.2 Microgen Business Overview
7.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.16.4 Microgen BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.16.5 Microgen Key News
7.17 Torlakinstitut
7.17.1 Torlakinstitut Corporate Summary
7.17.2 Torlakinstitut Business Overview
7.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.17.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.17.5 Torlakinstitut Key News
7.18 Institut Pasteur de Tunis
7.18.1 Institut Pasteur de Tunis Corporate Summary
7.18.2 Institut Pasteur de Tunis Business Overview
7.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.18.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.18.5 Institut Pasteur de Tunis Key News
7.19 IVAC
7.19.1 IVAC Corporate Summary
7.19.2 IVAC Business Overview
7.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.19.4 IVAC BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.19.5 IVAC Key News
8 Global BCG Vaccine for Tuberculosis (TB) Production Capacity, Analysis
8.1 Global BCG Vaccine for Tuberculosis (TB) Production Capacity, 2017-2028
8.2 BCG Vaccine for Tuberculosis (TB) Production Capacity of Key Manufacturers in Global Market
8.3 Global BCG Vaccine for Tuberculosis (TB) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BCG Vaccine for Tuberculosis (TB) Supply Chain Analysis
10.1 BCG Vaccine for Tuberculosis (TB) Industry Value Chain
10.2 BCG Vaccine for Tuberculosis (TB) Upstream Market
10.3 BCG Vaccine for Tuberculosis (TB) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 BCG Vaccine for Tuberculosis (TB) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
BCG Vaccine for Tuberculosis (TB) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|